T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
19/26/19	₩2,075.00	+2.22%	1,09,978
16/26/16	₩2,030.00	+4.26%	1,03,221
15/26/15	₩1,947.00	-5.02%	2,76,888
14/26/14	₩2,050.00	0.00%	1,06,945
13/26/13	₩2,050.00	-0.73%	2,62,742

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 19/10/2026			5-day change	1st Jan Change
2,075.00 ^KRW	+2.22%		-5.68%	-46.93%

21/01	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/24/23	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	9.89TCr 7.43Cr 6.63Cr 6.13Cr 5.59Cr 10Cr 704.53Cr 11Cr 74Cr 29Cr 367.85Cr 28Cr 27Cr 1.18TCr	P/E 2024	-12.2x	P/E 2025	-3.91x
Enterprise Value	12TCr 9.06Cr 8.08Cr 7.48Cr 6.81Cr 13Cr 859.13Cr 13Cr 90Cr 35Cr 448.57Cr 34Cr 33Cr 1.44TCr	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	85.08%	Yield 2024 *	-	Yield 2025	-

21/01	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/24/23	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
05/24/05	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
23/24/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
04/24/04	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
25/24/25	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
22/23/22	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
14/23/14	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
18/23/18	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
04/23/04	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
26/23/26	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
15/23/15	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
20/21/20	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	+2.22%
1 week	-5.68%
Current month	-2.58%
1 month	-8.79%
3 months	-0.24%
6 months	-37.69%
Current year	-46.93%

T&R Biofab Co., Ltd. Share Price

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news: T&R Biofab Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

1 week	1,918	2,090
1 month	1,918	2,380
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	9,250
5 years	1,127	29,625
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	57	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
06/03/25	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
06/03/25	Eun-kyung Cho	Others		15,492	0.0719%
26/02/25	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	+2.22%	-5.68%	+37.95%	-76.71%	7.26Cr
ABBOTT LABORATORIES	-0.79%	+4.48%	-19.04%	+8.89%	18TCr
MEDTRONIC PLC	-2.09%	+4.85%	-3.14%	+27.61%	12TCr
STRYKER CORPORATION	+1.11%	+7.43%	-20.43%	+10.27%	11TCr
ESSILORLUXOTTICA	-1.52%	+3.89%	-51.34%	-7.07%	7.98TCr
CENCORA, INC.	-0.27%	+4.99%	+4.72%	+79.37%	6.51TCr
HOYA CORPORATION	-0.27%	+2.10%	+15.54%	+66.81%	5.43TCr
BECTON, DICKINSON AND COMPANY	-0.53%	+3.80%	+0.87%	-26.47%	5.22TCr
IDEXX LABORATORIES, INC.	-0.81%	+7.30%	-12.53%	+30.68%	4.41TCr
DEXCOM, INC.	-0.07%	+2.22%	+29.10%	+2.21%	3.25TCr
Average	-0.37%	+4.78%	-1.83%	+11.56%	7.39TCr
Weighted average by Cap.	-0.82%	+5.50%	-11.69%	+19.29%

	2024	2025
Net sales	487.37Cr 36.6L 32.65L 30.22L 27.54L 51.61L 35Cr 52.39L 3.63Cr 1.42Cr 18Cr 1.37Cr 1.34Cr 58Cr	2.7TCr 2.03Cr 1.81Cr 1.67Cr 1.52Cr 2.86Cr 192.11Cr 2.9Cr 20Cr 7.88Cr 100.31Cr 7.59Cr 7.43Cr 321.61Cr
Net income	-767.88Cr -57.67L -51.45L -47.61L -43.39L -81.32L -55Cr -82.55L -5.72Cr -2.24Cr -29Cr -2.16Cr -2.12Cr -92Cr	-3.2TCr -2.4Cr -2.14Cr -1.98Cr -1.81Cr -3.38Cr -227.62Cr -3.43Cr -24Cr -9.34Cr -118.85Cr -9Cr -8.81Cr -381.05Cr
Net Debt	2.88TCr 2.16Cr 1.93Cr 1.78Cr 1.63Cr 3.05Cr 205.03Cr 3.09Cr 21Cr 8.41Cr 107.05Cr 8.1Cr 7.93Cr 343.24Cr	2.17TCr 1.63Cr 1.45Cr 1.35Cr 1.23Cr 2.3Cr 154.6Cr 2.33Cr 16Cr 6.34Cr 81Cr 6.11Cr 5.98Cr 258.82Cr